Article

Foot Orthoses Help Patellofemoral Pain Syndrome

For persons with patellofemoral pain syndrome (PFPS), the combination of 3 of 4 predictors-poor footwear motion control properties, less usual pain, reduced ankle dorsiflexion range of motion, and reduced pain during a single-leg squat-increases the probability of showing marked improvement with foot orthoses

For persons with patellofemoral pain syndrome (PFPS), the combination of 3 of 4 predictors-poor footwear motion control properties, less usual pain, reduced ankle dorsiflexion range of motion, and reduced pain during a single-leg squat-increases the probability of showing marked improvement with foot orthoses. A preliminary clinical prediction rule may help clinical reasoning when foot orthosis prescription is considered.

Barton and associates studied 60 patients with PFPS. Prefabricated foot orthoses were issued, and patients entered in a diary their daily physical activity completed, what footwear they wore, and how often they used the foot orthosis. At 12 weeks, each patient rated the perceived improvement in symptoms using a 5-point Likert scale.

Marked improvement at 12 weeks was reported by 14 patients. The greatest accuracy in predicting marked improvement was produced by positive findings on 3 of the 4 variables (footwear motion control properties score of less than 5.0, usual pain less than 22 mm, ankle dorsiflexion range of motion less than 41.3°, and reduced single-leg squat pain when wearing the orthoses).

The authors noted that this is the first clinical prediction rule study to evaluate the association of footwear properties, functional performance measures, and compliance with orthoses use.


Comments about/problems with this article? Please send feedback.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.